科托努硫酸镁对严重子痫前期和子痫神经学表现的治疗

IF 0.1
A. Lokossou, D. Avode, D. Komongui, I. Takpara, Pc Sacca, R. Perrin
{"title":"科托努硫酸镁对严重子痫前期和子痫神经学表现的治疗","authors":"A. Lokossou, D. Avode, D. Komongui, I. Takpara, Pc Sacca, R. Perrin","doi":"10.4314/AJNS.V25I1.7578","DOIUrl":null,"url":null,"abstract":"Le sulfate de magnesium(MgSO4) utilise depuis des decennies aux USA est reconnu plus efficace que le diazepam ou les phenytoines dans la prevention et le traitements des crises d\\'eclampsie, responsables d\\'une mortalite elevee.\n\nObjectif \nEvaluer l\\'efficacite et la tolerance du MgSO4 en milieu africain a Cotonou(BENIN) ou la frequence et la letalite dues a l\\'eclampsie demeurent des plus elevees.\n\nMateriel et methode \nIl s\\'agissait d\\'une etude a la fois retrospective et prospective a visee descriptive et analytique menee pendant 30 mois a l\\'Hopital de la Mere et Enfant Lagune(HOMEL) de Cotonou. L\\'echantillon etait constitue de patientes presentant une pre- eclampsie severe ou une eclampsie et qui etaient traitees par MgSO4 en dose d\\'attaque et d\\'entretien. L\\'administration du produit etait rigoureusement surveillee afin de diagnostiquer un surdosage. L\\'efficacite de MgSO4 etait evaluee sur l\\'amendement des signes neurologiques, le score d\\'APGAR a 1 et 5 mn de vie, la morbidite et la mortalite maternelles et neonatales etant comparees a celles rapportees dans une serie de 2001a l\\'HOMEL.\n\nResultats \n760 cas sur 17.753 accouchements etaient colliges (4,28% des accouchements ) ; 211 (âge moyen 24,74 ans) etaient traites par du MgSO4. Les pressions arterielles systolique et diastolique etaient comprises respectivement entre 160- 200 et 110- 120 mm Hg dans 83 et 86% des cas, accompagnees de crises convulsives(63%), d\\'obnubilation et de coma (13 et 12% respectivement) • L\\'efficacite du MgSO4 etait nette en termes d\\'amendement complet des crises convulsives (54% des cas) des l\\'administration de la dose d\\'attaque. Le score d\\'APGAR etait satisfaisant a la 1ere et 5eme mn de vie respectivement chez 69 et 84% des nouveaux- nes. La mortalite neonatale et la letalite maternelle (de 4 et 0,94% respectivement) etaient ameliorees par rapport aux taux d\\'une serie de 2001 (de 20,8 et 8,05% respectivement) a l\\'HOMEL de Cotonou avant l\\'introduction du MgSO4.\n\nConclusion \nLe sulfate de magnesium sous reserve d\\'une surveillance clinique rigoureuse etait reellement efficace sur les manifestations neurologiques de la pre- eclampsie severe et de l\\'eclampsie.\n\n The sulphate of magnesium(MgSO4) used since decades in USA is recognized more efficient than diazepam or phenytoins in the prevention and the treatment of the eclampsia seizures, responsible of an elevated mortality.\n\nObjectif \nTo Value the efficiency and the tolerance of MgSO4 in African environment in Cotonou(BENIN) where the frequency and the lethality due to eclampsia stay of the most elevated.\n\nMaterial and method \nIt was a retrospective and prospective, analytic and descriptive survey achieved during 30 months in the Mother and Child Hospital Lagoon(HOMEL) of Cotonou. The sample was constituted of patients presenting preeclampsia and eclampsia neurological symptoms and who were treated by MgSO4 in attack and maintenance dose. The treatment was supervised to diagnose overdose. The efficiency of MgSO4 was valued on the neurological sign amendment, the score of APGAR at 1 and 5 min. of life, the maternal and neonatal morbidity and mortality and neonatales being compared to those returned in a set of 2001at the HOMEL.\n\nResults \n760 cases on 17.753 childbirths were collected (4,28% of the childbirths); 211 (middle age of 24,74 years) were treated by MgSO4. Systolic and diastolic arterial blood pressures were consisted respectively between 160 - 200 and 110 - 120 Hgs mm in 83 and 86% of the cases, accompanied by seizures(63%), obnubilation and coma (13 and 12% respectively). The efficiency of MgSO4 was clean in terms of complete amendment of the seizures (54%) since the administration of the attack dose. The score of APGAR was satisfactory at the 1st and 5th minites of life respectively at 69 and 84% of the new - born. The neonatal mortality and the maternal lethality (of 4 and 0,94% respectively) were improven in relation to the rates of a set of 2001 (of 20,8 and 8,05% respectively) at the HOMEL of Cotonou before the introduction of MgSO4.\n\nConclusion \nMgSO4 subject to a rigorous clinic follow up was really efficient on the neurological manifestations of the preeclampsia and eclampsia .\n\n Keywords : neurological manifestations - Preeclampsia - Eclampsia - MgSO4 - BENIN. African Journal of Neurological Sciences Vol. 25 (1) 2006: pp. 41-49","PeriodicalId":42149,"journal":{"name":"African Journal of Neurological Sciences","volume":"25 1","pages":""},"PeriodicalIF":0.1000,"publicationDate":"2008-08-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":"{\"title\":\"Prise En Charge Des Manifestations Neurologiques De La Pre- Eclampsie Severe Et De L\\\\'eclampsie Par Le Sulfate De Magnesium A Cotonou\",\"authors\":\"A. Lokossou, D. Avode, D. Komongui, I. Takpara, Pc Sacca, R. Perrin\",\"doi\":\"10.4314/AJNS.V25I1.7578\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Le sulfate de magnesium(MgSO4) utilise depuis des decennies aux USA est reconnu plus efficace que le diazepam ou les phenytoines dans la prevention et le traitements des crises d\\\\'eclampsie, responsables d\\\\'une mortalite elevee.\\n\\nObjectif \\nEvaluer l\\\\'efficacite et la tolerance du MgSO4 en milieu africain a Cotonou(BENIN) ou la frequence et la letalite dues a l\\\\'eclampsie demeurent des plus elevees.\\n\\nMateriel et methode \\nIl s\\\\'agissait d\\\\'une etude a la fois retrospective et prospective a visee descriptive et analytique menee pendant 30 mois a l\\\\'Hopital de la Mere et Enfant Lagune(HOMEL) de Cotonou. L\\\\'echantillon etait constitue de patientes presentant une pre- eclampsie severe ou une eclampsie et qui etaient traitees par MgSO4 en dose d\\\\'attaque et d\\\\'entretien. L\\\\'administration du produit etait rigoureusement surveillee afin de diagnostiquer un surdosage. L\\\\'efficacite de MgSO4 etait evaluee sur l\\\\'amendement des signes neurologiques, le score d\\\\'APGAR a 1 et 5 mn de vie, la morbidite et la mortalite maternelles et neonatales etant comparees a celles rapportees dans une serie de 2001a l\\\\'HOMEL.\\n\\nResultats \\n760 cas sur 17.753 accouchements etaient colliges (4,28% des accouchements ) ; 211 (âge moyen 24,74 ans) etaient traites par du MgSO4. Les pressions arterielles systolique et diastolique etaient comprises respectivement entre 160- 200 et 110- 120 mm Hg dans 83 et 86% des cas, accompagnees de crises convulsives(63%), d\\\\'obnubilation et de coma (13 et 12% respectivement) • L\\\\'efficacite du MgSO4 etait nette en termes d\\\\'amendement complet des crises convulsives (54% des cas) des l\\\\'administration de la dose d\\\\'attaque. Le score d\\\\'APGAR etait satisfaisant a la 1ere et 5eme mn de vie respectivement chez 69 et 84% des nouveaux- nes. La mortalite neonatale et la letalite maternelle (de 4 et 0,94% respectivement) etaient ameliorees par rapport aux taux d\\\\'une serie de 2001 (de 20,8 et 8,05% respectivement) a l\\\\'HOMEL de Cotonou avant l\\\\'introduction du MgSO4.\\n\\nConclusion \\nLe sulfate de magnesium sous reserve d\\\\'une surveillance clinique rigoureuse etait reellement efficace sur les manifestations neurologiques de la pre- eclampsie severe et de l\\\\'eclampsie.\\n\\n The sulphate of magnesium(MgSO4) used since decades in USA is recognized more efficient than diazepam or phenytoins in the prevention and the treatment of the eclampsia seizures, responsible of an elevated mortality.\\n\\nObjectif \\nTo Value the efficiency and the tolerance of MgSO4 in African environment in Cotonou(BENIN) where the frequency and the lethality due to eclampsia stay of the most elevated.\\n\\nMaterial and method \\nIt was a retrospective and prospective, analytic and descriptive survey achieved during 30 months in the Mother and Child Hospital Lagoon(HOMEL) of Cotonou. The sample was constituted of patients presenting preeclampsia and eclampsia neurological symptoms and who were treated by MgSO4 in attack and maintenance dose. The treatment was supervised to diagnose overdose. The efficiency of MgSO4 was valued on the neurological sign amendment, the score of APGAR at 1 and 5 min. of life, the maternal and neonatal morbidity and mortality and neonatales being compared to those returned in a set of 2001at the HOMEL.\\n\\nResults \\n760 cases on 17.753 childbirths were collected (4,28% of the childbirths); 211 (middle age of 24,74 years) were treated by MgSO4. Systolic and diastolic arterial blood pressures were consisted respectively between 160 - 200 and 110 - 120 Hgs mm in 83 and 86% of the cases, accompanied by seizures(63%), obnubilation and coma (13 and 12% respectively). The efficiency of MgSO4 was clean in terms of complete amendment of the seizures (54%) since the administration of the attack dose. The score of APGAR was satisfactory at the 1st and 5th minites of life respectively at 69 and 84% of the new - born. The neonatal mortality and the maternal lethality (of 4 and 0,94% respectively) were improven in relation to the rates of a set of 2001 (of 20,8 and 8,05% respectively) at the HOMEL of Cotonou before the introduction of MgSO4.\\n\\nConclusion \\nMgSO4 subject to a rigorous clinic follow up was really efficient on the neurological manifestations of the preeclampsia and eclampsia .\\n\\n Keywords : neurological manifestations - Preeclampsia - Eclampsia - MgSO4 - BENIN. African Journal of Neurological Sciences Vol. 25 (1) 2006: pp. 41-49\",\"PeriodicalId\":42149,\"journal\":{\"name\":\"African Journal of Neurological Sciences\",\"volume\":\"25 1\",\"pages\":\"\"},\"PeriodicalIF\":0.1000,\"publicationDate\":\"2008-08-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"African Journal of Neurological Sciences\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4314/AJNS.V25I1.7578\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"African Journal of Neurological Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4314/AJNS.V25I1.7578","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2

摘要

硫酸镁(MgSO4)在美国已经使用了几十年,在预防和治疗导致高死亡率的子痫发作方面,它被认为比地西泮或苯托氨酸更有效。目的评估MgSO4在非洲科托努(贝宁)的有效性和耐受性,那里子痫的频率和致死率仍然很高。材料和方法这是一项回顾性和前瞻性的描述性和分析性研究,在科托努的拉古纳母亲和儿童医院(HOMEL)进行了30个月。该样本包括有严重子痫前期或子痫的患者,并接受MgSO4的攻击和维持剂量治疗。该产品的使用受到严格监测,以诊断过量。评估了MgSO4在神经体征修正、1分钟和5分钟阿普加评分、产妇和新生儿发病率和死亡率方面的有效性,并与2001年L\' homel系列报道的进行了比较。结果17753例分娩中760例(占分娩的4.28%);211人(平均年龄24.74岁)接受MgSO4治疗。压力arterielles收缩压和舒张压分别包括来自160 - 200美元至110 - 120毫米汞柱83和86%的案例中,accompagnees convulsives危机(63%)、d \’obnubilation和昏迷(分别是13%和12%)•L . \’efficacite MgSO4净去修改\ d .全面危机convulsives而言(54%)的案件的L \ \ d剂量行政处理。69%和84%的新生儿在生命的第1分钟和第5分钟apgar评分令人满意。新生儿死亡率和产妇死亡率(分别为4和0.94%)比2001年在科托努homel引入MgSO4之前的一系列死亡率(分别为20.8%和8.05%)有所改善。结论在严格的临床监测下,硫酸镁对严重子痫前期和子痫的神经系统表现有效。在美国使用了几十年的硫酸镁(MgSO4)在预防和治疗子痫发作方面比安定或苯妥英更有效,而子痫发作是造成高死亡率的原因。目的是评估MgSO4在贝宁科托努的非洲环境中的效率和耐受性,在那里,子痫的发病率和致病性仍然最高。材料和方法这是在科托努泻湖母婴医院(HOMEL) 30个月期间进行的一项回顾性、前瞻性、分析性和描述性调查。该样本包括有子痫前期和子痫神经症状的患者以及接受MgSO4治疗的患者。治疗被监督诊断为过量。通过以下方面评估了MgSO4的有效性:神经体征修正、生命1分钟和5分钟阿普加评分、产妇和新生儿发病率和死亡率以及新生儿与2001年9月在霍默医院报告的发病率和死亡率进行比较。收集了17753例子女出生760例(占子女出生总数的4.28%);= =地理= =根据美国人口普查,该县的总面积为,其中土地和(0.984平方公里)水。在83例和86%的病例中,收缩压和舒张压分别为160 - 200和110 - 120 Hgs mm,并伴有癫痫(63%)、昏厥和昏迷(分别为13和12%)。MgSO4的效率是干净的,因为自使用攻击剂量以来,对剂量进行了全面修订(54%)。= =地理= =根据美国人口普查,这个县的面积为,其中土地面积为,其中土地面积为。新生儿死亡率和产妇死亡率(分别为4和0.94%)相对于2001年9月采用MgSO4之前科托努家庭的死亡率(分别为20.8和8.05%)有所提高。结论MgSO4经严格的临床随访,对子痫前期和子痫的神经表现有效。关键词:神经学表现-子痫前期-子痫- MgSO4 -贝宁。非洲神经科学杂志第25卷(1)2006:41-49页
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Prise En Charge Des Manifestations Neurologiques De La Pre- Eclampsie Severe Et De L\'eclampsie Par Le Sulfate De Magnesium A Cotonou
Le sulfate de magnesium(MgSO4) utilise depuis des decennies aux USA est reconnu plus efficace que le diazepam ou les phenytoines dans la prevention et le traitements des crises d\'eclampsie, responsables d\'une mortalite elevee. Objectif Evaluer l\'efficacite et la tolerance du MgSO4 en milieu africain a Cotonou(BENIN) ou la frequence et la letalite dues a l\'eclampsie demeurent des plus elevees. Materiel et methode Il s\'agissait d\'une etude a la fois retrospective et prospective a visee descriptive et analytique menee pendant 30 mois a l\'Hopital de la Mere et Enfant Lagune(HOMEL) de Cotonou. L\'echantillon etait constitue de patientes presentant une pre- eclampsie severe ou une eclampsie et qui etaient traitees par MgSO4 en dose d\'attaque et d\'entretien. L\'administration du produit etait rigoureusement surveillee afin de diagnostiquer un surdosage. L\'efficacite de MgSO4 etait evaluee sur l\'amendement des signes neurologiques, le score d\'APGAR a 1 et 5 mn de vie, la morbidite et la mortalite maternelles et neonatales etant comparees a celles rapportees dans une serie de 2001a l\'HOMEL. Resultats 760 cas sur 17.753 accouchements etaient colliges (4,28% des accouchements ) ; 211 (âge moyen 24,74 ans) etaient traites par du MgSO4. Les pressions arterielles systolique et diastolique etaient comprises respectivement entre 160- 200 et 110- 120 mm Hg dans 83 et 86% des cas, accompagnees de crises convulsives(63%), d\'obnubilation et de coma (13 et 12% respectivement) • L\'efficacite du MgSO4 etait nette en termes d\'amendement complet des crises convulsives (54% des cas) des l\'administration de la dose d\'attaque. Le score d\'APGAR etait satisfaisant a la 1ere et 5eme mn de vie respectivement chez 69 et 84% des nouveaux- nes. La mortalite neonatale et la letalite maternelle (de 4 et 0,94% respectivement) etaient ameliorees par rapport aux taux d\'une serie de 2001 (de 20,8 et 8,05% respectivement) a l\'HOMEL de Cotonou avant l\'introduction du MgSO4. Conclusion Le sulfate de magnesium sous reserve d\'une surveillance clinique rigoureuse etait reellement efficace sur les manifestations neurologiques de la pre- eclampsie severe et de l\'eclampsie. The sulphate of magnesium(MgSO4) used since decades in USA is recognized more efficient than diazepam or phenytoins in the prevention and the treatment of the eclampsia seizures, responsible of an elevated mortality. Objectif To Value the efficiency and the tolerance of MgSO4 in African environment in Cotonou(BENIN) where the frequency and the lethality due to eclampsia stay of the most elevated. Material and method It was a retrospective and prospective, analytic and descriptive survey achieved during 30 months in the Mother and Child Hospital Lagoon(HOMEL) of Cotonou. The sample was constituted of patients presenting preeclampsia and eclampsia neurological symptoms and who were treated by MgSO4 in attack and maintenance dose. The treatment was supervised to diagnose overdose. The efficiency of MgSO4 was valued on the neurological sign amendment, the score of APGAR at 1 and 5 min. of life, the maternal and neonatal morbidity and mortality and neonatales being compared to those returned in a set of 2001at the HOMEL. Results 760 cases on 17.753 childbirths were collected (4,28% of the childbirths); 211 (middle age of 24,74 years) were treated by MgSO4. Systolic and diastolic arterial blood pressures were consisted respectively between 160 - 200 and 110 - 120 Hgs mm in 83 and 86% of the cases, accompanied by seizures(63%), obnubilation and coma (13 and 12% respectively). The efficiency of MgSO4 was clean in terms of complete amendment of the seizures (54%) since the administration of the attack dose. The score of APGAR was satisfactory at the 1st and 5th minites of life respectively at 69 and 84% of the new - born. The neonatal mortality and the maternal lethality (of 4 and 0,94% respectively) were improven in relation to the rates of a set of 2001 (of 20,8 and 8,05% respectively) at the HOMEL of Cotonou before the introduction of MgSO4. Conclusion MgSO4 subject to a rigorous clinic follow up was really efficient on the neurological manifestations of the preeclampsia and eclampsia . Keywords : neurological manifestations - Preeclampsia - Eclampsia - MgSO4 - BENIN. African Journal of Neurological Sciences Vol. 25 (1) 2006: pp. 41-49
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信